Tag: cell manufacturing

EV NMC Battery Market to Reach USD 70.8 Billion by 2030, Driven by Rapid Electrification and High-Energy Density Demand | Valuates Reports

What is the Market Size of the EV NMC Battery Market? BANGALORE, India, Aug. 13, 2025 /PRNewswire/ -- The global EV NMC Battery Market was valued...

EV NMC Battery Market to Reach USD 70.8 Billion by 2030, Driven by Rapid Electrification and High-Energy Density Demand | Valuates Reports

What is the Market Size of the EV NMC Battery Market? BANGALORE, India, Aug. 13, 2025 /PRNewswire/ -- The global EV NMC Battery Market was valued...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Over the last ten years, cell-based immunotherapy has emerged as a promising approach for treating solid tumors. Several companies, including Iovance Biotherapeutics, Obsidian Therapeutics,...

REPEAT – Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

WARREN, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders.

REPEAT – Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

WARREN, N.J., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced an update on institutional ownership of the Company’s outstanding common stock, as reported by institutional investment managers on Form 13F filed with the Securities and Exchange Commission (SEC).

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsCell manufacturing

Antag Therapeutics presents positive Phase 1 results at the 2026 Scientific Sessions of the American Diabetes Association for AT7687, a first-in-class GIPR antagonist

CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF ¥84,200,000,000 Japanese Yen Callable Senior Non-Preferred Bonds issued on June 3, 2021 (ISIN: JP525022AM69)

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VERI

Tag: cell manufacturing

EV NMC Battery Market to Reach USD 70.8 Billion by 2030, Driven by Rapid Electrification and High-Energy Density Demand | Valuates Reports

EV NMC Battery Market to Reach USD 70.8 Billion by 2030, Driven by Rapid Electrification and High-Energy Density Demand | Valuates Reports

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

Tumor-Infiltrating Lymphocyte Therapy Market Gains Momentum with Expanding Oncology Applications | DelveInsight

REPEAT – Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

REPEAT – Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us